Health & Wellness

Regenerative Medicine for Dogs: What Actually Works?

February 5, 20269 min readClaire Greenway, BVM&S, MRCVS

Stem cells, PRP, and other regenerative treatments are increasingly available for dogs. But what does the evidence actually show? Here's a balanced look at what's promising, what's unproven, and what questions to ask.

Regenerative medicine is one of the most talked-about areas in veterinary orthopaedics right now. Pet owners hear about stem cell injections, platelet-rich plasma, and other treatments that promise to heal damaged joints rather than just manage symptoms.

The appeal is obvious. Instead of painkillers for life, why not repair the underlying problem? Instead of surgery, why not regenerate the tissue?

It's an exciting field. But it's also one where marketing often runs ahead of evidence, costs are significant, and outcomes vary widely.

This article aims to give you a realistic picture. What treatments exist, what we know about them, what we don't know, and how to make informed decisions if you're considering these options for your dog.

What Is Regenerative Medicine?

Regenerative medicine refers to treatments that aim to repair, replace, or regenerate damaged tissues rather than simply managing symptoms. In canine orthopaedics, this typically means:

Stem cell therapy

Using the dog's own stem cells (or donor cells) to promote tissue repair.

Platelet-rich plasma (PRP)

Concentrating platelets from the dog's blood and injecting them into damaged areas.

Other biologics

Various preparations derived from blood, fat, or other tissues that contain growth factors and anti-inflammatory compounds.

The theory behind all of these is similar. Deliver concentrated healing factors directly to damaged tissue, and the body will repair itself more effectively than it would on its own. Whether that theory translates into meaningful clinical outcomes is where things get complicated.

Stem Cell Therapy

Stem cells are the most well-known regenerative treatment, and probably the most hyped.

How It Works

Stem cells are harvested from the dog's own body, typically from fat tissue (adipose-derived) or bone marrow. The cells are processed to concentrate them, then injected into the affected joint or tissue.

Adipose-derived

Fat is collected (usually from the abdomen or chest), processed to extract stem cells, and injected. Can sometimes be done in a single procedure.

Bone marrow-derived

Bone marrow is aspirated, processed, and the stem cells are concentrated. Similar principle, different source.

Cultured/expanded

Some facilities culture the cells in a lab to increase numbers before injection. Takes longer but delivers more cells.

What the Evidence Shows

Here's where we need to be honest. The evidence for stem cell therapy in dogs is mixed.

The positive:

  • • Some studies show improvement in lameness scores and owner-reported quality of life
  • • Dogs with osteoarthritis may show reduced pain and improved mobility
  • • The treatment appears safe with minimal side effects
  • • Some dogs respond remarkably well

The limitations:

  • • Many studies are small, lack control groups, or have methodological issues
  • • Placebo effect is significant
  • • Results are inconsistent
  • • Long-term outcomes are poorly documented
  • • We don't fully understand which dogs will respond

The unknowns:

  • • Optimal cell numbers and preparation methods
  • • How long effects last
  • • Whether repeated treatments are needed
  • • Which conditions respond best

A 2020 systematic review of stem cell therapy for canine osteoarthritis found "limited evidence" supporting its use, while noting that the studies that do exist show "promising" results. That's a fair summary of where we are. Promising, but not proven.

Cost

Stem cell therapy typically costs £1,500-4,000 in the UK, depending on the facility, technique used, and number of joints treated. That's a significant investment for a treatment with uncertain outcomes.

Platelet-Rich Plasma (PRP)

PRP has been used in human medicine for years, particularly in sports injuries. It's increasingly offered for dogs.

How It Works

Blood is drawn from the dog, then spun in a centrifuge to separate components. The platelet-rich layer is extracted and injected into the affected area.

Platelets contain growth factors that promote healing. By concentrating them and delivering them directly to damaged tissue, the theory is that healing is accelerated. The procedure is relatively quick and can often be done in a single visit.

What the Evidence Shows

The positive:

  • • Well-established in human medicine with reasonable evidence for certain conditions
  • • Some veterinary studies show improved outcomes in tendon and ligament injuries
  • • Appears safe with minimal complications
  • • May reduce inflammation and promote tissue repair
  • • Generally less expensive than stem cell therapy

The limitations:

  • • Evidence in dogs is still limited
  • • Preparation methods vary widely between clinics
  • • Results for osteoarthritis are less convincing than for soft tissue injuries
  • • Not all PRP is created equal — concentration and composition matter

Best evidence for:

Tendon injuries, ligament healing (as adjunct to surgery), wound healing

Weaker evidence for:

Established osteoarthritis, chronic joint disease, conditions where tissue is already severely degenerated

Cost

PRP typically costs £400-800 per treatment in the UK. More affordable than stem cells, but still a meaningful expense, especially if multiple treatments are needed.

Other Regenerative Treatments

Several other biologics are available or emerging.

Autologous Conditioned Serum (ACS/IRAP)

Blood is drawn, incubated to stimulate production of anti-inflammatory proteins (particularly interleukin-1 receptor antagonist), then injected into joints.

Some studies show benefit for joint inflammation. More established in horses than dogs. Cost: £300-600 per treatment.

Bone Marrow Aspirate Concentrate (BMAC)

Similar concept to stem cells but with less processing. Bone marrow is aspirated, concentrated, and injected.

Limited evidence in dogs. May contain both stem cells and growth factors. Less expensive than full stem cell processing.

Alpha-2-Macroglobulin (A2M)

A protein that may protect cartilage from degradation. Extracted from blood and injected into joints.

Very early stages. Some promising research but limited clinical data in dogs.

Amniotic/Placental Products

Derived from donor tissue, these contain growth factors and anti-inflammatory compounds.

Variable evidence. Some products better studied than others. Regulation varies.

Realistic Expectations

Let's be clear about what regenerative medicine can and cannot do right now.

What it might do:

  • • Reduce pain and inflammation
  • • Improve mobility and function
  • • Potentially slow disease progression
  • • Provide an alternative or complement to long-term medication
  • • Help some dogs that haven't responded to conventional treatment

What it probably can't do:

  • • Regrow severely damaged cartilage
  • • Reverse advanced arthritis
  • • Replace the need for weight management and appropriate exercise
  • • Work equally well for every dog
  • • Provide a permanent one-time cure

The honest picture: Some dogs respond remarkably well to regenerative treatments. But some dogs show no improvement at all. We're not yet good at predicting who will benefit. This is frustrating for owners who invest significant money hoping for improvement.

Who Might Be a Good Candidate?

Based on current understanding, regenerative medicine may be worth considering for:

Potentially good candidates:

  • • Dogs with mild to moderate osteoarthritis who haven't responded to conventional management
  • • Dogs who can't tolerate NSAIDs due to kidney, liver, or GI issues
  • • Post-surgical support to potentially improve healing
  • • Active dogs where owners want to explore beyond symptom management
  • • Cases where surgery isn't an option

Less ideal candidates:

  • • Dogs with severe, end-stage joint disease
  • • Dogs who haven't tried conventional management first
  • • Conditions where surgery is clearly indicated (e.g. ruptured cruciate ligament)

Questions to Ask Your Vet

If you're considering regenerative medicine, here's what to discuss:

About the treatment:

  • • "What specific treatment are you recommending, and why?"
  • • "What's the evidence base for this treatment?"
  • • "How many treatments will likely be needed?"
  • • "What's the expected timeline for results?"

About expectations:

  • • "What improvement can I realistically expect?"
  • • "What percentage of dogs respond to treatment?"
  • • "How will we measure whether it's working?"
  • • "What happens if it doesn't work?"

About the facility:

  • • "How many of these procedures have you performed?"
  • • "What outcomes have you seen in similar cases?"
  • • "Are you using validated, quality-controlled products?"

About alternatives:

  • • "What conventional treatments should we try first?"
  • • "Would surgery be more appropriate?"
  • • "Can this be combined with other treatments?"
  • • "What are the pros and cons vs. long-term medication?"

A good vet will welcome these questions. They should be able to discuss evidence honestly, including limitations, rather than just selling the treatment.

Red Flags to Watch For

Be cautious if you encounter:

Guaranteed results. No treatment works for every dog. Anyone promising certain outcomes isn't being honest.

Pressure to decide immediately. You should have time to research and consider options.

Dismissal of conventional treatments. Regenerative medicine should complement good veterinary care, not replace it.

Vague explanations. If they can't clearly explain what they're doing and why, that's concerning.

No follow-up plan. Good practitioners monitor outcomes and adjust treatment accordingly.

Combining Approaches

Regenerative medicine works best as part of a comprehensive management plan, not as a standalone treatment.

Weight management

Remains crucial. No injection will overcome the damage caused by excess body weight on joints.

Appropriate exercise

Keeps muscles strong and joints mobile. Low-impact, consistent activity matters.

Physical therapy

Can maximise the benefit of regenerative treatments by improving strength, flexibility, and function.

Pain management

May still be needed, at least initially. Some dogs can reduce or eliminate medications after successful treatment.

Monitoring

Tracks whether the treatment is actually working. Objective gait analysis can help measure improvement beyond subjective impressions.

The Future

Regenerative medicine in veterinary orthopaedics is advancing rapidly.

Better research

Larger, controlled studies will give clearer answers about what works and for whom.

Improved techniques

Processing and delivering cells may improve outcomes.

Better patient selection

As we learn which dogs respond best to which treatments.

Reduced costs

May come as techniques become more standardised and widespread.

In five or ten years, we'll likely have much clearer guidance on when regenerative medicine is appropriate and what results to expect. Right now, we're in a transitional period where the science is catching up to the clinical availability.

Making a Decision

If you're considering regenerative medicine for your dog, here's a framework:

Start with the basics. Is your dog at a healthy weight? Is their exercise appropriate? Have conventional treatments been properly tried?

Understand the condition. What exactly is wrong with your dog? Some conditions are better candidates than others.

Have realistic expectations. This might help. It might not. Are you prepared for either outcome?

Consider the cost. Is this a reasonable investment given the uncertainty? Could that money be better spent on other aspects of care?

Find the right provider. Experience, honesty, and proper follow-up matter more than fancy marketing.

Plan for monitoring. How will you know if it's working? Objective measurement helps.

The Bottom Line

Regenerative medicine offers genuine promise for some dogs with orthopaedic conditions. The treatments are generally safe, and some dogs experience significant improvement.

But it's not a miracle cure. The evidence is still developing, outcomes are unpredictable, and costs are substantial.

The best approach is balanced. Neither dismissing these treatments as worthless nor embracing them as the answer to everything. They're tools that may help some dogs in some situations, best used as part of comprehensive care with realistic expectations.

If you're considering this path, do your research, ask good questions, and work with practitioners who are honest about both the potential and the limitations. That's how good decisions get made.